Safety of Cardioversion of Acute Atrial Fibrillation "FinCV"


Phase N/A Results N/A

Summary of Purpose

The purpose of this study is to investigate the complications of cardioversion of acute (<48 hours duration) atrial fibrillation (AF). Primary Outcome Measures: - Incidence and predictors of thromboembolic complications, especially stroke, and death <31 days after cardioversion of acute AF Secondary Outcome Measures: - Number of therapy non-responder and early recurrence of AF - ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 June 2012.

1 Jun 2011 16 Jun 2011 1 May 2012 1 Jun 2012 1 Jun 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



Trial Design

  • Observation: Cohort
  • Perspective: Retrospective
  • Sampling: Non-Probability Sample


Not available